General Information of the Compound
| Compound ID |
CP0389926
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2-morpholin-4-yl-2-pyridin-2-ylethyl)-4-(3-quinolin-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H31N7O3
|
||||||||||||||||||
| Molecular Weight |
513.602
|
||||||||||||||||||
| Canonical SMILES |
O=C(NCC(N1CCOCC1)c1ccccn1)N1CCC(CC1)c1nc(no1)-c1ccc2ccccc2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H31N7O3/c36-28(30-19-25(23-7-3-4-12-29-23)34-15-17-37-18-16-34)35-13-10-21(11-14-35)27-32-26(33-38-27)24-9-8-20-5-1-2-6-22(20)31-24/h1-9,12,21,25H,10-11,13-19H2,(H,30,36)
Show/Hide
|
||||||||||||||||||
| InChIKey |
RLSOOBWWRNNSNI-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound